SE8704689D0 - Nya mellanprodukter for framstellning av histamin-h?712-receptor-antagonister och forfarande for framstellning derav - Google Patents

Nya mellanprodukter for framstellning av histamin-h?712-receptor-antagonister och forfarande for framstellning derav

Info

Publication number
SE8704689D0
SE8704689D0 SE8704689A SE8704689A SE8704689D0 SE 8704689 D0 SE8704689 D0 SE 8704689D0 SE 8704689 A SE8704689 A SE 8704689A SE 8704689 A SE8704689 A SE 8704689A SE 8704689 D0 SE8704689 D0 SE 8704689D0
Authority
SE
Sweden
Prior art keywords
histamine
receptor antagonists
procedures
producing
manufacturing
Prior art date
Application number
SE8704689A
Other languages
English (en)
Other versions
SE464302B (sv
SE8704689L (sv
Inventor
R R Crenshaw
A A Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8704689L publication Critical patent/SE8704689L/sv
Publication of SE8704689D0 publication Critical patent/SE8704689D0/sv
Publication of SE464302B publication Critical patent/SE464302B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
SE8704689A 1982-03-29 1987-11-25 Etandiimidamider som mellanprodukter foer framstaellning av histamin -h2-receptorantagonister och foerfarande foer framstaellning daerav SE464302B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (3)

Publication Number Publication Date
SE8704689L SE8704689L (sv) 1987-11-25
SE8704689D0 true SE8704689D0 (sv) 1987-11-25
SE464302B SE464302B (sv) 1991-04-08

Family

ID=23429274

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8301725A SE461040B (sv) 1982-03-29 1983-03-28 Substituerade 3,4-diamino-1,2,5-tiadiazoler samt foerfarande foer framstaellning daerav
SE8704689A SE464302B (sv) 1982-03-29 1987-11-25 Etandiimidamider som mellanprodukter foer framstaellning av histamin -h2-receptorantagonister och foerfarande foer framstaellning daerav

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8301725A SE461040B (sv) 1982-03-29 1983-03-28 Substituerade 3,4-diamino-1,2,5-tiadiazoler samt foerfarande foer framstaellning daerav

Country Status (30)

Country Link
JP (2) JPS58180477A (sv)
KR (1) KR880002209B1 (sv)
AT (1) AT386599B (sv)
AU (2) AU557577B2 (sv)
BE (1) BE896291A (sv)
CH (2) CH660880A5 (sv)
CS (2) CS250229B2 (sv)
DD (2) DD219768A5 (sv)
DE (1) DE3311281A1 (sv)
DK (2) DK166677B1 (sv)
ES (3) ES520982A0 (sv)
FR (2) FR2542741B1 (sv)
GB (2) GB2117769B (sv)
GR (1) GR78524B (sv)
HU (2) HU196386B (sv)
IE (1) IE55596B1 (sv)
IL (1) IL68259A0 (sv)
IT (1) IT1164633B (sv)
LU (1) LU84716A1 (sv)
MY (1) MY8700942A (sv)
NL (1) NL8301063A (sv)
NO (1) NO163055C (sv)
NZ (1) NZ203726A (sv)
OA (1) OA07356A (sv)
PT (1) PT76459B (sv)
SE (2) SE461040B (sv)
SU (2) SU1419518A3 (sv)
YU (1) YU44849B (sv)
ZA (1) ZA832154B (sv)
ZW (1) ZW7683A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
ES8505978A1 (es) 1985-06-16
NZ203726A (en) 1986-05-09
SE464302B (sv) 1991-04-08
SU1419518A3 (ru) 1988-08-23
SE8301725D0 (sv) 1983-03-28
PT76459B (en) 1986-03-11
DK166677B1 (da) 1993-06-28
IT1164633B (it) 1987-04-15
GB2117769B (en) 1985-08-29
YU74483A (en) 1986-02-28
FR2542741B1 (fr) 1989-12-08
SE8301725L (sv) 1983-11-25
IE55596B1 (en) 1990-11-21
GB2149406A (en) 1985-06-12
SE461040B (sv) 1989-12-18
FR2597867A1 (fr) 1987-10-30
NO163055C (no) 1990-03-28
GR78524B (sv) 1984-09-27
JPH06135925A (ja) 1994-05-17
HU188742B (en) 1986-05-28
CH655111A5 (de) 1986-03-27
JPH0568472B2 (sv) 1993-09-29
KR840004095A (ko) 1984-10-06
DK81192D0 (da) 1992-06-18
SU1355123A3 (ru) 1987-11-23
AU1290783A (en) 1983-10-06
ES8404683A1 (es) 1984-05-16
AU586037B2 (en) 1989-06-29
DK141383A (da) 1983-09-30
AU6327286A (en) 1987-01-08
SE8704689L (sv) 1987-11-25
ATA111083A (de) 1988-02-15
NO163055B (no) 1989-12-18
KR880002209B1 (ko) 1988-10-18
ES527685A0 (es) 1985-06-16
PT76459A (en) 1983-04-01
IL68259A0 (en) 1983-06-15
FR2542741A1 (fr) 1984-09-21
GB8432809D0 (en) 1985-02-06
LU84716A1 (fr) 1983-12-05
HU196386B (en) 1988-11-28
FR2597867B1 (fr) 1989-12-08
DD219768A5 (de) 1985-03-13
ES8505977A1 (es) 1985-06-16
IT8348005A0 (it) 1983-03-28
DK81192A (da) 1992-06-18
ZA832154B (en) 1983-12-28
CS250240B2 (en) 1987-04-16
BE896291A (fr) 1983-09-28
ES527686A0 (es) 1985-06-16
DD210909A5 (de) 1984-06-27
NO831100L (no) 1983-09-30
GB2149406B (en) 1986-01-02
DK141383D0 (da) 1983-03-28
MY8700942A (en) 1987-12-31
ES520982A0 (es) 1984-05-16
GB8308518D0 (en) 1983-05-05
NL8301063A (nl) 1983-10-17
YU44849B (en) 1991-04-30
DE3311281A1 (de) 1983-11-24
AU557577B2 (en) 1986-12-24
JPS58180477A (ja) 1983-10-21
IE830686L (en) 1983-09-29
ZW7683A1 (en) 1984-01-04
CH660880A5 (de) 1987-05-29
CS250229B2 (en) 1987-04-16
OA07356A (fr) 1984-08-31
GB2117769A (en) 1983-10-19
AT386599B (de) 1988-09-12

Similar Documents

Publication Publication Date Title
SE8005534L (sv) Kinolinkarboxylsyraderivat och sett for framstellning derav
FI804085L (fi) Foerfarande foer framstaellning av nya sulfonamider
SE7908481L (sv) Nya 5h-2,3-bensodiazepinderivat och forfarande for framstellning derav
HUT56099A (en) Process for producing 2-(2-amino-thiazol-4-yl)-2-(4-pyridon-2-yl-methoxy-imino)-acetic acid derivatives
AU593207B2 (en) Novel phenyl-substituted sulfonamides
ES8602721A1 (es) Un procedimiento para la preparacion de antagonistas de los receptores h-2 de la histamina.
SE8002293L (sv) Nya antisekretoriska foreningar och deras anvendningsomrade
SE8704689D0 (sv) Nya mellanprodukter for framstellning av histamin-h?712-receptor-antagonister och forfarande for framstellning derav
FI800770A (fi) Nya indolderivater deras framstaellning och deras anvaendning saosom laekemedel
FI881816A (fi) Nya bicykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
ES8308326A1 (es) Procedimiento para la preparacion de amidobenzamidas.
SE8204418D0 (sv) N-imidazolyl-derivat av 1,2,3,4-tetrahydronaftalen, indan och 2-substituerad-1-kroman, och forfarande for deras framstellning
AU550340B2 (en) Dibenzazepine derivatives
SE8100236L (sv) Nya tioler och forfarande for framstellning derav
DE3468104D1 (en) New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use
SE8503110D0 (sv) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h?712-receptor antagonist activity
SE8300580D0 (sv) Substituerade 1,3,4-tiadiazolo (3,2-a)pyrimidiner och forfarande for deras framstellning
ES506022A0 (es) Un procedimiento para la preparacion de derivados acilicos de cefalosporina
FI843363A0 (fi) Flaven- och tioflavenderivat, foerfarande foer deras framstaellning, farmaceutiska preparat innehaollande saodana foereningar och anvaendning av de sistnaemnda.
PT77194A (fr) Procede de preparation de derives de phenethyl-1-alpha-phenyl-1-piperidine-3-propanenitrile et de compositions pharmaceutiques les contenant
FI870098A (fi) Nya pregnanderivat, foerfaranden foer deras framstaellning och farmaceutiska preparat, vilka innehaoller desamma.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8704689-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8704689-2

Format of ref document f/p: F